Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127608231 | 12760823 | 1 | I | 20100322 | 20110330 | 20160919 | 20160919 | EXP | US-ASTRAZENECA-2016SE99544 | ASTRAZENECA | 1.00 | YR | F | Y | 0.00000 | 20160920 | MD | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127608231 | 12760823 | 1 | PS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 0 | INJECTION | ||||||||||
127608231 | 12760823 | 2 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 0 | INJECTION | ||||||||||
127608231 | 12760823 | 3 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 100 MG | 0 | INJECTION | |||||||||
127608231 | 12760823 | 4 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 100 MG | 0 | INJECTION | |||||||||
127608231 | 12760823 | 5 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 150 MG | 0 | INJECTION | |||||||||
127608231 | 12760823 | 6 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 150 MG | 0 | INJECTION | |||||||||
127608231 | 12760823 | 7 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 150 MG | 0 | INJECTION | |||||||||
127608231 | 12760823 | 8 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 150 MG | 0 | INJECTION | |||||||||
127608231 | 12760823 | 9 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 150 MG | 0 | INJECTION | |||||||||
127608231 | 12760823 | 10 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 150 MG | 0 | INJECTION | |||||||||
127608231 | 12760823 | 11 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 150 MG | 0 | INJECTION | |||||||||
127608231 | 12760823 | 12 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 150 MG | 0 | INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127608231 | 12760823 | 1 | Antiviral prophylaxis |
127608231 | 12760823 | 2 | Heart disease congenital |
127608231 | 12760823 | 3 | Antiviral prophylaxis |
127608231 | 12760823 | 4 | Heart disease congenital |
127608231 | 12760823 | 5 | Antiviral prophylaxis |
127608231 | 12760823 | 6 | Heart disease congenital |
127608231 | 12760823 | 7 | Antiviral prophylaxis |
127608231 | 12760823 | 8 | Heart disease congenital |
127608231 | 12760823 | 9 | Antiviral prophylaxis |
127608231 | 12760823 | 10 | Heart disease congenital |
127608231 | 12760823 | 11 | Antiviral prophylaxis |
127608231 | 12760823 | 12 | Heart disease congenital |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127608231 | 12760823 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127608231 | 12760823 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127608231 | 12760823 | 1 | 20090325 | 20090325 | 0 | |
127608231 | 12760823 | 2 | 20090325 | 20090325 | 0 | |
127608231 | 12760823 | 3 | 20091006 | 20091006 | 0 | |
127608231 | 12760823 | 4 | 20091006 | 20091006 | 0 | |
127608231 | 12760823 | 5 | 20091208 | 20091208 | 0 | |
127608231 | 12760823 | 6 | 20091208 | 20091208 | 0 | |
127608231 | 12760823 | 7 | 20100107 | 20100107 | 0 | |
127608231 | 12760823 | 8 | 20100107 | 20100107 | 0 | |
127608231 | 12760823 | 9 | 20100211 | 20100211 | 0 | |
127608231 | 12760823 | 10 | 20100211 | 20100211 | 0 | |
127608231 | 12760823 | 11 | 20100408 | 20100408 | 0 | |
127608231 | 12760823 | 12 | 20100408 | 20100408 | 0 |